MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

03 Feb 2023 Evaluate
A decent increase of about 51.39% in the turnover to Rs. 281.65 millions was observed for the quarter ended December 2022. The turnover stood at Rs. 186.04 millions during the similar quarter previous year.A comparatively good net profit growth of 37.72% to Rs. 98.07 millions was reported for the quarter ended December 2022 compared to Rs. 71.21 millions of previous same quarter.Operating profit surged to 139.17 millions from the corresponding previous quarter of 104.89 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 281.65 186.04 51.39 1208.00 860.91 40.32 1148.54 905.63 26.82
Other Income 18.06 6.93 160.61 46.25 25.41 82.01 40.50 32.67 23.97
PBIDT 139.17 104.89 32.68 639.17 475.06 34.55 620.95 435.95 42.44
Interest 0.71 3.27 -78.29 1.75 6.49 -73.04 8.28 9.81 -15.60
PBDT 138.46 101.62 36.25 637.42 468.57 36.04 612.67 426.14 43.77
Depreciation 6.58 5.71 15.24 18.07 16.89 6.99 22.33 17.32 28.93
PBT 131.88 95.91 37.50 619.35 451.68 37.12 590.34 408.82 44.40
TAX 33.81 24.70 36.88 156.58 113.33 38.16 154.10 107.02 43.99
Deferred Tax 1.77 0.34 420.59 2.51 0.10 2410.00 0.72 1.26 -42.86
PAT 98.07 71.21 37.72 462.77 338.35 36.77 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 49.41 56.38 -12.36 52.91 55.18 -4.11 54.06 48.14 12.31
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..